Nova Minerals Limited ("Nova" or the "Company") (NASDAQ: NVA) (ASX: NVA) (FRA: QM3)) is pleased to announce that preparations ...

Valvoline Global is set to make its partnership debut with FIFA's flagship tournament.The sponsorship reflects the rapid ...

KELOWNA, BC / ACCESS Newswire / May 30, 2025 / Avant Brands Inc. (TSX:AVNT)(OTCQX:AVTBF)(FRA:1BU0) ("Avant" or the "Company"), a leading producer of innovative and award-winning cannabis products, hel ...

ANAHEIM, CA / ACCESS Newswire / May 30, 2025 / Phoenix Motor Inc. (OTC PINK:PEVM), a leading manufacturer of heavy-duty transit buses and electrification solutions provider for medium-duty vehicles, t ...

VANCOUVER, BC / ACCESS Newswire / May 30, 2025 / GLG Life Tech Corporation (TSX:GLG) ("GLG" or the "Company"), a global leader in the agricultural and commercial development of high-quality zero-calor ...

Zedcor Inc. (TSXV: ZDC) (the "Company" or "Zedcor") announces that on May 29, 2025, 2,935,000 Restricted Share Units (RSUs) were granted to employees ...

First Quantum Minerals Ltd. ("First Quantum" or the "Company") (TSX: FM) announces that Minera Panamá S.A., a subsidiary of First Quantum, has received approval ...

VANCOUVER, BC / ACCESS Newswire / May 30, 2025 / Metavista3D Inc. (TSXV:DDD)(FSE:E3T) ("Metavista3D" or the "Company") is providing this bi-weekly default status report in accordance with National Pol ...

Very Polite Agency is pleased to announce it is a Gold Sponsor at the Centurion One Capital 6th Annual LA Summit held at the iconic Beverly ...

SAN ANTONIO, TEXAS / ACCESS Newswire / May 30, 2025 / To keep the spotlight on women in global aviation and aerospace in recent months, Olga Custodio's release of her awe-inspiring memoir, Flightpath ...

Cancellation of 6,899,011 ordinary shares held in treasury by EQTThe cancellation was resolved by the Annual Shareholders' Meeting 2025As of 30 May 2025, there are 1,177,185,346 shares outstanding ...

PALO ALTO, CA / ACCESS Newswire / May 30, 2025 / Riboscience, LLC, today announced the presentation of data from the completed dose escalation Phase 1a of the Phase 1a/b clinical trial of the ENPP1 in ...